Pediatrics
Partner With Us
Advertisement

Rare Diseases

thumb description

June 13, 2025

Also in the News…

From EU approval for a pharmacological myopia treatment to startling disparities in cornea specialist coverage across the US, these are the news stories and studies that caught our attention this week…

The Ophthalmologist

thumb description

June 10, 2025

FDA Pledges Week-Long Drug Reviews

New leadership outlines accelerated approval processes, AI integration, and food additive restrictions to address the chronic disease epidemic

Conexiant

thumb description

June 06, 2025

New Global Criteria Define Pediatric Bone Disease

An international team developed and validated the first global classification criteria for pediatric chronic nonbacterial osteomyelitis, offering a standardized tool to improve research and diagnosis.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

thumb description

May 29, 2025

FDA Approves First Hydrocortisone Oral Solution

The FDA has approved Khindivi, the first hydrocortisone oral solution for pediatric adrenal insufficiency, offering precise, ready-to-use dosing for patients aged 5 years and older.

Conexiant

thumb description

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

thumb description

May 26, 2025

New Study Unveils Potential Therapeutic Pathways for Aggressive Pediatric Brain Tumor

A groundbreaking study led by researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and the Broad Institute of MIT and Harvard has uncovered critical insights into the biology of embryonal tumor with multilayered rosettes (ETMR), a rare and aggressive brain tumor affecting young children. 

Dana-Farber